UPDATE: JP Morgan Raises PT on Perrigo from $82 to $88

J.P. Morgan has published a research report on Perrigo Company PRGO, raising the price target by $6. In the report, J.P. Morgan wrote, "We are modestly increasing our sales and EPS stimates following Perrigo's FY4Q/11 results and FY2012 guidance. The company reported a relatively in-line quarter but more importantly provided better-than-expected FY2012 top-line guidance that calls for 15-18% growth." J.P. Morgan rated Perrigo a Neutral with a price target raised from $82.00 to $88.00. Perrigo closed Tuesday at $89.56.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareJ.P. Morgan ChasePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!